Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway ; volume:9 ; number:1 ; day:16 ; month:9 ; year:2010 ; pages:1-15 ; date:12.2010
Molecular cancer ; 9, Heft 1 (16.9.2010), 1-15, 12.2010
- Creator
-
Yoshihara, Tatsuya
Takahashi-Yanaga, Fumi
Shiraishi, Fumie
Morimoto, Sachio
Watanabe, Yutaka
Hirata, Masato
Hoka, Sumio
Sasaguri, Toshiyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-245
- URN
-
urn:nbn:de:101:1-2021080918534431058869
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoshihara, Tatsuya
- Takahashi-Yanaga, Fumi
- Shiraishi, Fumie
- Morimoto, Sachio
- Watanabe, Yutaka
- Hirata, Masato
- Hoka, Sumio
- Sasaguri, Toshiyuki
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Notch regulates the angiogenic response via induction of VEGFR-1
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Notch regulates the angiogenic response via induction of VEGFR-1
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Notch regulates the angiogenic response via induction of VEGFR-1
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors